Adiponectin and Metabolic Syndrome

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 1, 2004, Pages 29-33

  Matsuzawa, Yuji ^a,b   Funahashi, Tohru ^a   Kihara, Shinji ^a   Shimomura, Iichiro ^a  

^a SUMITOMO HOSPITAL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Adipocytokines; Adiponectin; Multiple risk factors; Visceral fat

Indexed keywords

ADIPONECTIN;

ADIPOCYTE; ATHEROSCLEROSIS; GENE STRUCTURE; HUMAN; HYPOADIPONECTINEMIA; INSULIN RESISTANCE; LIPID STORAGE; METABOLIC DISORDER; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; VASCULAR DISEASE;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ARTERIOSCLEROSIS; DIABETES MELLITUS; GENE EXPRESSION PROFILING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; METABOLIC SYNDROME X; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; OBESITY; ORGAN SPECIFICITY; PROTEINS; SUBCUTANEOUS TISSUE; VISCERA;

EID: 0345861775     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000099786.99623.EF     Document Type: Short Survey

References (36)

1. The World Health Report 2002. Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
3. Kaplan NM. The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med. 1989;149:1514-1520.
4. Matsuzawa YM. Pathophysiology and molecular mechanism of visceral fat syndrome: the Japanese case. Diabetes Metab Rev. 1997;13:3-13.
5. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism. Metabolism. 1987;36:54-59.
6. Kanai H, Matsuzawa Y, Kotani K, Keno Y, Kobatake T, Nagai Y, Fujioka S, Tokunaga K, Tarui S. Close correlation of intraabdominal fat accumulation to hypertension in obese women. Hypertension. 1990;16:484-490.
7. Despres JP, Moorjani M, Ferland M, Tremblay A, Lupien PJ, Nadeau A, Pinault S, Theriault G, Bouchard C. Adipose tissue distribution and plasma lipoprotein levels in obese women: importance of intraabdominal fat. Arteriosclerosis. 1989;9:203-210.
8. Despres JP, Nadeau A, Tremblay A, Ferland M, Moorjani S, Lupien PJ, Theriault G, Pinault S, Bouchard C. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes. 1989;38:304-309.
9. Nakamura T, Tokunaga K, Shimomura I, Nishida M, Yoshida S, Kotani K, Islam AHMW, Keno Y, Kobatake T, Nagai Y, Fujioka S, Tarui S, Matsuzawa Y. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese subjects. Atherosclerosis. 1994;107:239-246.
10. Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y, Matsubara K. Analysis of expression profile of genes in the human adipose tissue. Gene. 1997;190:227-235.
11. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med. 1999;38:202-206.
12. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: possible contribution to vascular disease in obesity. Nature Med. 1996;2:1-5.
13. Matsumoto S, Kishida K, Maeda N, Nagaredani H, Matsuda M, Nishizawa H, Kihara S, Funahashi T, Matsuzawa Y, Yamada A, Yamashita S, Tamura S, Kawata S. Increased plasma HB-EGF associated with obesity and coronary artery disease. Biochem Biophys Res Commun. 2002;292:781-786.
14. Paganelli F, Alessi MC, Morange P, Maixent JM, Levy S, Vague IJ. Relationship of plasminogen activator inhibitor-I levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. Thromb Haemost. 1999;82:104-108.
15. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM l(adipose most abundant gene transcript-1). Biochem Biophys Res Commun. 1996;221:286-289.
16. Scherer EP, Williams S, Fogliano M, Baldin G, Lodish HF. A novel serum protein similar to C1q produced exclusively in adipocytes. J Biol Chem. 1995;270:26740-26744.
17. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996;271:10697-10703.
18. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Muraguchi H, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
19. Takahashi M, Funahashi T, Shimomura I, Miyaoka Y, Matsuzawa Y. Plasma leptin levels and body fat distribution. Horm Metab Res. 1996;28:751-752.
20. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPARγ ligands increase expression and plasma concentration of adiponectin, an adipose-derived protein. Diabetes. 2001;50:2094-2099.
21. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Matsuzawa Y. Plasma concentrations of a novel adipose-specific protein, adiponectin, in type 2 diabetic agents. Arterioscler Thromb Vasc Biol. 2000;20:1595-1599.
22. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002;360:57-58.
23. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration and low plasma concentration precedes a decrease in whole body insulin sensitivity in humans. Diabetes. 2002;51:I884-I888.
24. Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Adiponectin and essential hypertension. J Nephrol. 2002:15:507-511.
25. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Matsuzawa Y. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003;23:85-89.
26. Zoccali C, Mallamaci F, Tripepi G, Benedetto FAQ, Cutrupi S, Parlongo S, Malatino LS, Monanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Kihara S, Funahashi T, Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:134-141.
27. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y, Kihara S, Nakamura T, Yamashita S, Miyagawa J, Funahashi T, Matsuzawa Y. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res. 2000;32:47-50.
28. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein. Circulation. 1999;100:2473-2476.
29. Ouchi Y, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Adiponectin, adipocyte-derived plasma protein, inhibits endothelial NFκB signaling through cAMP-dependent pathway. Circulation. 2000;102:1296-1301.
30. Ouchi Y, Kihara S, Arita Y, Nishida M, Matsushima A, Okamoto Y, Ishigami M, Kuriyama H, Kishda K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y. Adipocyte-derived plasma protein, adiponectin, suppress lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 2001;103:1057-1063.
31. Arita Y, Kihara S, Ouchi Y, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Adipocyte-derived plasma protein, adiponectin, acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation. 2002;105:2893-2898.
32. Takahashi M, Arita Y, Yamagata Y, Okutomi K, Horie M, Shimomura I, Hotta K, Kuriyama H, Ouchi Y, Maeda K, Nishida M, H, Kihara S, Nakamura, Yamashita S, Funahashi T, Matsuzawa Y. Genomic structure and mutation in adipose-specific gene, adiponectin. Int J Obes Relat Disord. 2000;24:861-868.
33. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, Ouchi Y, Kihara S, Kawamoto T, Sumotuji S, Funahashi T, Matsuzawa Y. Association of adiponectin mutation, with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes. 2002;51:2325-2328.
34. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8:731-737.
35. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Marda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y. Role of adiponectin in preventing vascular stenosis: the missing link of adipovascular axis. J Biol Chem. 2002;277:37487-37491.
36. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Fuahashi T, Matsuzawa Y. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2002;26:2767-2770.